Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
Year: 2022
Type: article
Abstract: The cellular prion protein PrP C mediates the neurotoxicity of prions and other protein aggregates through poorly understood mechanisms. Antibody-derived ligands against the globular domain of PrP C (GDL) can also initiate neurotoxicity by inducing an intramolecular R 208 -H 140 hydrogen bond (“H-latch”) between the α2-α3 and β2-α2 loops of PrP C . Importantly, GDL that suppress the H-latch prolong the life of prion-infected mice, suggesting that GDL toxicity and prion infections exploit convergent pathways. To define the structural underpinnings of these phenomena, we transduced nineteen individual PrP C variants to PrP C -deficient cerebellar organotypic cultured slices using adenovirus-associated viral vectors (AAV). We report that GDL toxicity requires a single N-proximal cationic residue (K 27 or R 27 ) within PrP C . Alanine substitution of K 27 also prevented the toxicity of PrP C mutants that induce Shmerling syndrome, a neurodegenerative disease that is suppressed by co-expression of wild-type PrP C . K 27 may represent an actionable target for compounds aimed at preventing prion-related neurodegeneration.
Source: Brain Pathology
DOI: 10.1111/bpa.13130
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,700
Funders: National Science Foundation, Michael J. Fox Foundation for Parkinson's Research, Fondazione Gelu, Human Frontier Science Program, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Stavros Niarchos Foundation, Universität Zürich, Baugarten Stiftung, NOMIS Stiftung, Universitätsspital Zürich, Innosuisse - Schweizerische Agentur für Innovationsförderung, Horizon 2020 Framework Programme, H2020 European Research Council
Awards: G1027777368, Modifiers and cofactors of prion replication, toxicity and tropism, G3144639796, G3368800296, The prion protein in health and disease, PrP and its receptor GPR126: guardians of axomyelinic integrity and druggable targets against demyelinating diseases, G6740798628, G6955226848, G7944295140, G7983326833, Function and malfunction of the prion protein
OpenAlex ID: W4308182087
